Mortality and functional outcomes 18 months after hospitalization for COVID-19 in geriatric patients: a multicentric cohort study.
Long-term mortality
Older
Prognosis
SARS-CoV2
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
17 Sep 2024
17 Sep 2024
Historique:
received:
22
11
2023
accepted:
24
07
2024
medline:
18
9
2024
pubmed:
18
9
2024
entrez:
17
9
2024
Statut:
epublish
Résumé
Few data are available on the long-term mortality and functional status of geriatric patients surviving after hospitalization for COVID-19. We compared the mortality and functional status 18 months after hospitalization for geriatric patients who were hospitalized for COVID-19 or another diagnosis. This was a multicentric cohort study in Paris from January to June 2021. We included patients aged 75 years and over who were hospitalized with COVID-19 or not during this period and compared their vital and functional status 18 months after hospitalization. We included 254 patients (63 hospitalized for COVID-19). As compared with patients hospitalized for other reasons, those hospitalized for COVID-19 were younger (mean [SD] age 86 [6.47] vs. 88 [6.41] years, p = 0.03), less frail (median Clinical Frailty Scale score 5 [4-6] vs. 6 [4-6], p 0.007) and more independent at baseline (median activities of daily living score 5.5 [4-6] vs. 5 [3.5-6], p 0.03; instrumental activities of daily living score 3 [1-4] vs. 2 [0-3], p 0.04). At 18 months, 50.8% (n = 32/63) of COVID-19 patients had died versus 66% (n = 126/191) of non-COVID-19 patients (p 0.03). On multivariate analysis, COVID-19 positivity was not significantly associated with 18-month mortality (adjusted hazard ratio 0.67, 95% confidence interval 0.40 to 1.13). At 18 months, the two groups did not differ in activities of daily living or frailty scores. In this multicenter study of long-term mortality in geriatric patients discharged alive after hospitalization, positive COVID-19 status was not associated with excess mortality.
Sections du résumé
BACKGROUND
BACKGROUND
Few data are available on the long-term mortality and functional status of geriatric patients surviving after hospitalization for COVID-19. We compared the mortality and functional status 18 months after hospitalization for geriatric patients who were hospitalized for COVID-19 or another diagnosis.
METHODS
METHODS
This was a multicentric cohort study in Paris from January to June 2021. We included patients aged 75 years and over who were hospitalized with COVID-19 or not during this period and compared their vital and functional status 18 months after hospitalization.
RESULTS
RESULTS
We included 254 patients (63 hospitalized for COVID-19). As compared with patients hospitalized for other reasons, those hospitalized for COVID-19 were younger (mean [SD] age 86 [6.47] vs. 88 [6.41] years, p = 0.03), less frail (median Clinical Frailty Scale score 5 [4-6] vs. 6 [4-6], p 0.007) and more independent at baseline (median activities of daily living score 5.5 [4-6] vs. 5 [3.5-6], p 0.03; instrumental activities of daily living score 3 [1-4] vs. 2 [0-3], p 0.04). At 18 months, 50.8% (n = 32/63) of COVID-19 patients had died versus 66% (n = 126/191) of non-COVID-19 patients (p 0.03). On multivariate analysis, COVID-19 positivity was not significantly associated with 18-month mortality (adjusted hazard ratio 0.67, 95% confidence interval 0.40 to 1.13). At 18 months, the two groups did not differ in activities of daily living or frailty scores.
CONCLUSIONS
CONCLUSIONS
In this multicenter study of long-term mortality in geriatric patients discharged alive after hospitalization, positive COVID-19 status was not associated with excess mortality.
Identifiants
pubmed: 39289641
doi: 10.1186/s12877-024-05240-6
pii: 10.1186/s12877-024-05240-6
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
763Informations de copyright
© 2024. The Author(s).
Références
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–33. https://doi.org/10.1056/NEJMoa2001017 .
pubmed: 31978945
pmcid: 7092803
doi: 10.1056/NEJMoa2001017
WHO Coronavirus (COVID-19) Dashboard. May 2024. https://covid19.who.int/ Accessed June 1, 2024.
Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): a review. JAMA. 2020;324:782–93. https://doi.org/10.1001/jama.2020.12839 .
pubmed: 32648899
doi: 10.1001/jama.2020.12839
Chavda VP, Patel AB, Vaghasiya DD. SARS-CoV‐2 variants and vulnerability at the global level. J Med Virol. 2022;94:2986–3005. https://doi.org/10.1002/jmv.27717 .
pubmed: 35277864
pmcid: 9088647
doi: 10.1002/jmv.27717
The RECOVERY Collaborative Group. (2021). Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693–704. https://doi.org/10.1056/NEJMoa2021436
Annweiler C, Sacco G, Salles N, et al. National French Survey of Coronavirus Disease (COVID-19) symptoms in people aged 70 and over. Clin Infect Dis. 2020;72:490–4. https://doi.org/10.1093/cid/ciaa792 .
pmcid: 7337693
doi: 10.1093/cid/ciaa792
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323:2052–9. https://doi.org/10.1001/jama.2020.6775 .
pubmed: 32320003
pmcid: 7177629
doi: 10.1001/jama.2020.6775
Zerah L, Baudouin É, Pépin M, et al. Clinical characteristics and outcomes of 821 older patients with SARS-Cov-2 infection admitted to Acute Care Geriatric wards. J Gerontol Biol Sci Med Sci Glaa. 2020;210. https://doi.org/10.1093/gerona/glaa210 .
Volpato S, Bazzano S, Fontana A, et al. Multidimensional Prognostic Index predicts mortality and length of Stay during hospitalization in the older patients: a Multicenter prospective study. J Gerontol Biol Sci Med Sci. 2015;70:323–9. https://doi.org/10.1093/gerona/glu167 .
doi: 10.1093/gerona/glu167
Chojnicki M, Neumann-Podczaska A, Seostianin M, et al. Long-term survival of older patients hospitalized for COVID-19. Do clinical characteristics upon Admission Matter? Int J Environ Res Public Health. 2021;18:10671. https://doi.org/10.3390/ijerph182010671 .
pubmed: 34682421
pmcid: 8535841
doi: 10.3390/ijerph182010671
Walle-Hansen MM, Ranhoff AH, Mellingsæter M, et al. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021;21:199. https://doi.org/10.1186/s12877-021-02140-x .
pubmed: 33752614
pmcid: 7983098
doi: 10.1186/s12877-021-02140-x
Carrillo-Garcia P, Garmendia-Prieto B, Cristofori G, et al. Health status in survivors older than 70 years after hospitalization with COVID-19: observational follow-up study at 3 months. Eur Geriatr Med. 2021;12:1091–4. https://doi.org/10.1007/s41999-021-00516-1 .
pubmed: 34057701
pmcid: 8165338
doi: 10.1007/s41999-021-00516-1
Günster C, Busse R, Spoden M, et al. 6-month mortality and readmissions of hospitalized COVID-19 patients: a nationwide cohort study of 8,679 patients in Germany. PLoS ONE. 2021;16:e0255427. https://doi.org/10.1371/journal.pone.0255427 .
pubmed: 34351975
pmcid: 8341502
doi: 10.1371/journal.pone.0255427
Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747–58. https://doi.org/10.1016/S0140-6736(21)01755-4 .
pubmed: 34454673
pmcid: 8389999
doi: 10.1016/S0140-6736(21)01755-4
Becker RC. COVID-19 and its sequelae: a platform for optimal patient care, discovery and training. J Thromb Thrombolysis. 2021;51:587–94. https://doi.org/10.1007/s11239-021-02375-w .
pubmed: 33501596
pmcid: 7838017
doi: 10.1007/s11239-021-02375-w
Składanek JA, Leśkiewicz M, Gumiężna K et al. (2023) Long COVID and its cardiovascular consequences: what is known? Adv Clin Exp Med. https://doi.org/10.17219/acem/167482
Baroni C, Potito J, Perticone ME, et al. How does Long-COVID Impact Prognosis and the long-term sequelae? Viruses. 2023;15:1173. https://doi.org/10.3390/v15051173 .
pubmed: 37243259
pmcid: 10222218
doi: 10.3390/v15051173
WHO 2. COVID-19 Clinical management: living guidance. https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-clinical-2021-1 . Accessed November 13, 2021.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83. https://doi.org/10.1016/0021-9681(87)90171-8 .
pubmed: 3558716
doi: 10.1016/0021-9681(87)90171-8
Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489–95. https://doi.org/10.1503/cmaj.050051 .
pubmed: 16129869
pmcid: 1188185
doi: 10.1503/cmaj.050051
Katz S, Akpom CA. 12. Index of ADL. Med Care. 1976;14:116–8. https://doi.org/10.1097/00005650-197605001-00018 .
pubmed: 132585
doi: 10.1097/00005650-197605001-00018
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.
pubmed: 5349366
doi: 10.1093/geront/9.3_Part_1.179
Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989–95. https://doi.org/10.1016/j.jclinepi.2012.02.018 .
pubmed: 22742913
doi: 10.1016/j.jclinepi.2012.02.018
Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis: for the Third International Consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315:762–74. https://doi.org/10.1001/jama.2016.0288 .
pubmed: 26903335
pmcid: 5433435
doi: 10.1001/jama.2016.0288
Bhadhuri A, Kind P, Salari P, et al. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy. Health Qual Life Outcomes. 2020;18:317. https://doi.org/10.1186/s12955-020-01564-0 .
pubmed: 32993637
pmcid: 7526382
doi: 10.1186/s12955-020-01564-0
Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996;49:907–16. https://doi.org/10.1016/0895-4356(96)00025-x .
pubmed: 8699212
doi: 10.1016/0895-4356(96)00025-x
Prampart S, Le Gentil S, Bureau ML, et al. Functional decline, long term symptoms and course of frailty at 3-months follow-up in COVID-19 older survivors, a prospective observational cohort study. BMC Geriatr. 2022;22:542. https://doi.org/10.1186/s12877-022-03197-y .
pubmed: 35768781
pmcid: 9244035
doi: 10.1186/s12877-022-03197-y
RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:1637–45. https://doi.org/10.1016/S0140-6736(21)00676-0 .
doi: 10.1016/S0140-6736(21)00676-0
Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7. https://doi.org/10.1016/j.thromres.2020.04.013 .
pubmed: 32291094
pmcid: 7146714
doi: 10.1016/j.thromres.2020.04.013
Flumignan RL, Civile VT, Tinôco JD de S, et al. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022;2022(CD013739). https://doi.org/10.1002/14651858.CD013739.pub2 .
Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2034577 . NEJMoa2034577.
pubmed: 33301246
pmcid: 7745181
doi: 10.1056/NEJMoa2034577
Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99–111. https://doi.org/10.1016/S0140-6736(20)32661-1 .
pubmed: 33306989
pmcid: 7723445
doi: 10.1016/S0140-6736(20)32661-1
Walter LC, Brand RJ, Counsell SR, et al. Development and validation of a Prognostic Index for 1-Year mortality in older adults after hospitalization. JAMA. 2001;285:2987–94. https://doi.org/10.1001/jama.285.23.2987 .
pubmed: 11410097
doi: 10.1001/jama.285.23.2987
Engvig A, Wyller TB, Skovlund E, et al. Association between clinical frailty, illness severity and post-discharge survival: a prospective cohort study of older medical inpatients in Norway. Eur Geriatr Med. 2022;13:453–61. https://doi.org/10.1007/s41999-021-00555-8 .
pubmed: 34417977
doi: 10.1007/s41999-021-00555-8
Covinsky KE, Palmer RM, Fortinsky RH, et al. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc. 2003;51:451–8. https://doi.org/10.1046/j.1532-5415.2003.51152.x .
pubmed: 12657063
doi: 10.1046/j.1532-5415.2003.51152.x
Boyd CM, Landefeld CS, Counsell SR, et al. Recovery in activities of Daily Living among older adults following hospitalization for Acute Medical Illness. J Am Geriatr Soc. 2008;56:2171–9. https://doi.org/10.1111/j.1532-5415.2008.02023.x .
pubmed: 19093915
pmcid: 2717728
doi: 10.1111/j.1532-5415.2008.02023.x
Ferrara MC, Zarcone C, Tassistro E, et al. Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19? Aging Clin Exp Res. 2023;35:455–61. https://doi.org/10.1007/s40520-022-02308-4 .
pubmed: 36445566
doi: 10.1007/s40520-022-02308-4
Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021;398:2126–8. https://doi.org/10.1016/S0140-6736(21)02758-6 .
pubmed: 34871545
pmcid: 8640673
doi: 10.1016/S0140-6736(21)02758-6
Araf Y, Akter F, Tang Y, et al. Omicron variant of SARS-CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines. J Med Virol. 2022;94:1825–32. https://doi.org/10.1002/jmv.27588 .
pubmed: 35023191
pmcid: 9015557
doi: 10.1002/jmv.27588
Fernández-de-Las-Peñas C, Notarte KI, Peligro PJ, et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. 2022;14:2629. https://doi.org/10.3390/v14122629 .
pubmed: 36560633
pmcid: 9785120
doi: 10.3390/v14122629
Du M, Ma Y, Deng J, et al. Comparison of long COVID-19 caused by different SARS-CoV-2 strains: a systematic review and Meta-analysis. Int J Environ Res Public Health. 2022;19:16010. https://doi.org/10.3390/ijerph192316010 .
pubmed: 36498103
pmcid: 9736973
doi: 10.3390/ijerph192316010